{"id":"oxamarin","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["oxamarin hydrochloride","oxamarin","oxamarin HCl"],"offLabel":[],"synonyms":["oxamarin hydrochloride","oxamarin","oxamarin HCl"],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body's cells have locks on them, and OXAMARIN is a key that fits into one of those locks. When it binds, it can either unlock a beneficial process or block a harmful one, but the details of how it does this are not yet clear.","oneSentence":"OXAMARIN works by binding to a specific target, but the exact mechanism is unknown.","technicalDetail":"OXAMARIN's mechanism of action is not well understood, and further research is needed to elucidate its pharmacology."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3404","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=OXAMARIN","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T15:12:34.241759","biosimilars":[],"competitors":[],"genericName":"oxamarin","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"7M1L7AS5QJ","CHEBI":"CHEBI:135614","INN_ID":"1863","UMLSCUI":"C0604487","ChEMBL_ID":"CHEMBL2111036","KEGG_DRUG":"D05280","PUBCHEM_CID":"27190","SECONDARY_CAS_RN":"6830-17-7"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","brandName":"OXAMARIN","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"OXAMARIN is a small molecule drug with unknown target and drug class. Its commercial status is unclear, and it is not known whether it is FDA approved or off-patent. There is limited information available on its approved indications, half-life, and bioavailability. Further research is needed to understand its mechanism of action and key safety considerations. As a result, OXAMARIN is not widely recognized in the pharmaceutical industry.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}